Notes / Company

Panacea Biotec Ltd.

PANACEABIO BSE 531349 ISIN INE922B01023 Pharmaceuticals

Fundamentals

Market cap: ₹2,529 cr
ROE: 0.00%
Debt / equity: 0.03
52-week range: 292.40 — 522.90

The timeline — 1 note on Panacea Biotec Ltd.

May 2026

31 May 26 · 1:11 AM IST Brief

Brief · Earnings · Small cap

Panacea Biotec's auditor flags going concern as losses widen

Audited results for FY26 show a standalone net loss of ₹2,988 lakh, more than double the prior year, with the auditor questioning the company's ability to continue.

Verify on exchange BSE filings for PANACEABIO NSE filings for PANACEABIO